Strumento inattivo

Azioni VERA PHARADR Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA	05/06/17
Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference	23/05/17
Verona Pharma Announces Closing of Exercise of Underwriters’ Over-allotment Option	18/05/17
Grant of Options and RSUs and PDMR Dealings	03/05/17
Verona Pharma Announces Closing of Global Offering	02/05/17

Settore